Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial. - Boccardo,F.; Rubagotti,A.; Amoroso,D.; Mesiti,M.; Romeo,D.; Sismondi,P.; Giai,M.; Genta,F.; Pacini,P.; Distante,V.; Bolognesi,A.; Aldrighetti,D.; et al. (J Clin Oncol, 2000)